Cargando…

Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study

SIMPLE SUMMARY: In this study, we report that the combination of existing therapeutic agents and hemagglutinating virus of Japan envelope (HVJ-E), a virus-inactivating agent, may be a more effective treatment agent for pleural mesothelioma, a refractory cancer for which no effective treatment has be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakura, Kazuma, Sasai, Masao, Funaki, Soichiro, Shintani, Yasushi, Okumura, Meinoshin, Kaneda, Yasufumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913709/ https://www.ncbi.nlm.nih.gov/pubmed/36765886 http://dx.doi.org/10.3390/cancers15030929

Ejemplares similares

Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth
por: Lee, Che-Hsin, et al.
Publicado: (2017)

Boron-incorporating hemagglutinating virus of Japan envelope (HVJ-E) nanomaterial in boron neutron capture therapy
por: Yoneoka, Shuichiro, et al.
Publicado: (2019)

Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma
por: Sugii, Narushi, et al.
Publicado: (2020)

Surgical treatment strategies for invasive thymoma
por: Funaki, Soichiro, et al.
Publicado: (2020)

Preoperative evaluation and indications for pulmonary metastasectomy
por: Kanzaki, Ryu, et al.
Publicado: (2021)

Novel Prophylactic Vaccine Using a Prime-Boost Method and Hemagglutinating Virus of Japan-Envelope against Tuberculosis
por: Okada, Masaji, et al.
Publicado: (2011)

Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2020)

Pleuropneumonectomy for a large thymoma with multiple pleural dissemination using median sternotomy followed by posterolateral thoracotomy
por: Shintani, Yasushi, et al.
Publicado: (2015)

Podocalyxin influences malignant potential by controlling epithelial–mesenchymal transition in lung adenocarcinoma
por: Kusumoto, Hidenori, et al.
Publicado: (2017)

Debulking surgery for functional pleural dissemination of parathyroid carcinoma-case report
por: Kawagishi, Sachi, et al.
Publicado: (2021)

The Outcomes of Induction Chemoradiotherapy Followed by Surgery for Clinical T3-4 Non-Small Cell Lung Cancer
por: Kanzaki, Ryu, et al.
Publicado: (2019)

The prognostic impact of programmed cell death 1 and its ligand and the correlation with epithelial‐mesenchymal transition in thymic carcinoma
por: Funaki, Soichiro, et al.
Publicado: (2019)

Efficient Differentiation of Mouse Induced Pluripotent Stem Cells into Alveolar Epithelium Type II with a BRD4 Inhibitor
por: Momozane, Toru, et al.
Publicado: (2019)

Surgical options for treatment of metastatic pleural disease: extended abstract
por: Okumura, Meinoshin
Publicado: (2022)

A case of alpha-fetoprotein-positive thymic small cell carcinoma: a case report
por: Kobayashi, Masao, et al.
Publicado: (2023)

Anti-Ma2-Associated Limbic Encephalitis after Termination of Immune Checkpoint Inhibitor Therapy for Malignant Pleural Mesothelioma
por: Hashimoto, Rei, et al.
Publicado: (2021)

The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
por: Borgeaud, Maxime, et al.
Publicado: (2023)

Two cases of lobectomy for lung cancer after transcatheter aortic valve implantation
por: Nagata, Hideki, et al.
Publicado: (2018)

Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy
por: Kanzaki, Ryu, et al.
Publicado: (2017)

The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors
por: Kanzaki, Ryu, et al.
Publicado: (2020)

Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment
por: Iwahori, Kota, et al.
Publicado: (2019)

Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
por: Kim, Roger Y., et al.
Publicado: (2021)

CD7 Expression in Malignant Pleural Mesothelioma
por: Hibi, Shigeyoshi, et al.
Publicado: (1992)

A Novel Formulation of Cisplatin with γ-Polyglutamic Acid and Chitosan Reduces Its Adverse Renal Effects: An In Vitro and In Vivo Animal Study
por: Sasai, Masao, et al.
Publicado: (2021)

Non-Woven Sheet Containing Gemcitabine: Controlled Release Complex for Pancreatic Cancer Treatment
por: Sakura, Kazuma, et al.
Publicado: (2022)

Adipose Tissue-Derived Stem Cells Have the Ability to Differentiate into Alveolar Epithelial Cells and Ameliorate Lung Injury Caused by Elastase-Induced Emphysema in Mice
por: Fukui, Eriko, et al.
Publicado: (2019)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Physician requests by patients with malignant pleural mesothelioma in Japan
por: Nagamatsu, Yasuko, et al.
Publicado: (2019)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
por: Hotta, Katsuyuki, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis
por: Gemelli, Maria, et al.
Publicado: (2022)

Success of Checkpoint Blockade Paves the Way for Novel Immune Therapy in Malignant Pleural Mesothelioma
por: Rondon, Lizbeth, et al.
Publicado: (2023)

Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors
por: Yamamoto, Yoko, et al.
Publicado: (2020)

Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo
por: Fujii, Hitoshi, et al.
Publicado: (2011)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ddv6hch35n895a8skdaigi6cv5